Cynata Therapeutics Ltd (formerly Eco Quest Ltd) is a life sciences technology business based in Australia trading on the Australian Stock exchange (ASX Ticker CYP).
Forrest Capital's Role:
- Recapitalised Eco Quest (ASX:ECQ) and facilitated board changes (ECQ changed name to CYP at a later point).
- Introduced and managed the investment by ECQ of private stem cell company Cynata.
- Assisted with the execution of a worldwide exclusive license agreement by Cynata with WARF (commercialisation arm of The University of Wisconsin) covering the stem cell manufacturing technology.
- Negotiated the 100% acquisition of Cynata by ECQ, negotiated the appointment of Mr Ross MacDonald & Dr Stewart Washer to the board and raised $8 million as corporate adviser.